Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression

Inflammatory Bowel Diseases

Volumn 22, Issue 6, 2016, Pages 1391-1396

  Wasan, Sharmeel K ^a   Zullow, Samantha ^a   Berg, Adam ^a   Cheifetz, Adam S ^b   Ganley Leal, Lisa ^a   Farraye, Francis A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; immunization; ulcerative colitis; vaccination

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR; VARICELLA ZOSTER VACCINE; VIRUS ANTIBODY;

AGED; BLOOD; CELL CULTURE; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; MONONUCLEAR CELL; PROSPECTIVE STUDY; SECRETION (PROCESS);

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, VIRAL; CELLS, CULTURED; FEMALE; HERPES ZOSTER VACCINE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MESALAMINE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84970963388     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000743     Document Type: Article

References (19)

1. Wasan SK, Baker SE, Skolnik PR, et al. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105: 1231-1238.
2. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834-1840.
3. Cohen JI. Herpes zoster. N Engl J Med. 2013;369:1766-1767.
4. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2008;57:1-30; quiz CE32-CE34.
5. Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:1483-1490.
6. Long MD, Martin C, Sandler RS, et al. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:420-429.
7. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352: 2271-2284.
8. Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54:922-928.
9. Hales CM, Harpaz R, Ortega-Sanchez I, et al. Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63:729-731.
10. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17:2536-2540.
11. Lu Y, Bousvaros A. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr. 2010;50:562-565.
12. Zhang J, Xie F, Delzell E, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308:43-49.
13. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohns Relapse Prevention Trial. Am J Gastroenterol. 1996;91: 1571-1578.
14. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;105: 148-154.
15. Andrisani G, Frasca D, Romero M, et al. Immune response to influenza A/ H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-Alpha agents: effects of combined therapy with immunosuppressants. J Crohns Colitis. 2013;7:301-307.
16. Kaine JL, Kivitz AJ, Birbara C, et al. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol. 2007;34: 272-279.
17. Visvanathan S, Keenan GF, Baker DG, et al. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol. 2007;34:952-957.
18. Kapetanovic MC, Saxne T, Sjoholm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45:106-111.
19. Mease PJ, Ritchlin CT, Martin RW, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol. 2004;31:1356-1361.